Individual variation of somatic gene mutability in relation to cancer susceptibility: Prospective study on erythrocyte glycophorin A gene mutations of atomic bomb survivors

Cancer Research

Volumn 65, Issue 12, 2005, Pages 5462-5469

  Kyoizumi, Seishi ^a,b   Kusunoki, Yoichiro ^a   Hayashi, Tomonori ^a   Hakoda, Masayuki ^a   Cologne, John B ^a   Nakachi, Kei ^a  

^a RADIATION EFFECTS RESEARCH FOUNDATION   (Japan)

^b YASUDA WOMEN'S UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPHORIN A;

ARTICLE; ATOMIC BOMB SURVIVOR; BLOOD SAMPLING; BONE MARROW; CANCER INCIDENCE; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; ERYTHROCYTE; FEMALE; GENE LOCUS; GENE MUTATION; GENETIC VARIABILITY; HEMIZYGOSITY; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE; RADIATION EXPOSURE; RADIATION INJURY; RADIATION RESPONSE; SOMATIC MUTATION;

AGED; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, RADIATION; ERYTHROCYTES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLYCOPHORIN; HUMANS; MALE; MIDDLE AGED; MUTAGENESIS; MUTATION; NEOPLASMS, RADIATION-INDUCED; NUCLEAR WARFARE; PREVALENCE; SURVIVORS;

EID: 20444462766     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-1188     Document Type: Article

References (48)

1. Collins A, Harrington V. Repair of oxidative DNA damage: assessing its contribution to cancer prevention. Mutagenesis 2002;17:489-93.
2. Berwick M, Vineis P. Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review. J Natl Cancer Inst 2000;92:874-97.
3. Mohrenweiser HW, Wilson DM III, Jones IM. Challenges and complexities in estimating both the functional impact and the disease risk associated with the extensive genetic variation in human DNA repair genes. Mutat Res 2003;526:93-125.
4. Miller MC III, Mohrenweiser HW, Bell DA. Genetic variability in susceptibility and response to toxicants. Toxicol Lett 2001;120:269-80.
5. Goode EL, Ulrich CM, Potter JD. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev 2002;11:1513-30.
6. Bonassi S, Au WW. Biomarkers in molecular epidemiology studies for health risk prediction. Mutat Res 2002;511:73-86.
7. Bigbee WL, Langlois RG, Swift M, et al. Evidence for an elevated frequency of in vivo somatic cell mutations in ataxia telangiectasia. Am J Hum Genet 1989;44:402-8.
8. Kyoizumi S, Nakamura N, Takebe H, et al. Frequency of variant erythrocytes at the glycophorin-A locus in two Blooms syndrome patients. Mutat Res 1989;214:215-22.
9. Langlois RG, Bigbee WL, Jensen RH, et al. Evidence for increased in vivo mutation and somatic recombination in Bloom's syndrome. Proc Natl Acad Sci U S A 1989;86:670-4,
10. Sala-Trepat M, Boyse J, Richard P, et al. Frequencies of HPRT-lymphocytes and glycophorin A variants erythrocytes in Fanconi anemia patients, their parents and control donors. Mutat Res 1993;289:115-26.
11. Kyoizumi S, Kusunoki Y, Seyama T, et al. In vivo somatic mutations in Werners syndrome. Hum Genet 1998;103:405-10.
12. Moser MJ, Bigbee WL, Grant SG, et al. Genetic instability and hematologic disease risk in Werner syndrome patients and heterozygotes. Cancer Res 2000;60:2492-6.
13. Hewitt M, Mott MG. The assessment of in vivo somatic mutations in survivors of childhood malignancy. Br J Cancer 1992;66:143-7.
14. Roesch WC, editor. U.S.-Japan joint reassessment of atomic bomb radiation dosimetry in Hiroshima and Nagasaki, final report, vols. 1 and 2. Hiroshima: Radiation Effects Research Foundation; 1987.
15. Pierce DA, Shimizu Y, Preston DL, et al. Studies of the mortality of atomic bomb survivors. Report 12, Part I. Cancer: 1950-1990. Radiat Res 1996;146:1-27.
16. Kyoizumi S, Akiyama M, Cologne JB, et al. Somatic cell mutations at the glycophorin A locus in erythrocytes of atomic bomb survivors: implications for radiation carcinogenesis. Radiat Res 1996;146:43-52.
17. Mabuchi K, Soda M, Ron E, et al. Cancer incidence in atomic bomb survivors. Part I: Use of the tumor registries in Hiroshima and Nagasaki for incidence studies. Radiat Res 1994;137:S1-16.
18. Pierce DA, Stram DO, Vaeth M. Allowing for random errors in radiation dose estimates for the atomic bomb survivor data. Radiat Res 1990;123:275-84.
19. Langlois RG, Bigbee WL, Kyoizumi S, et al. Evidence for increased somatic cell mutations at the glycophorin A locus in atomic bomb survivors. Science 1987;236:445-8.
20. Kyoizumi S, Nakamura N, Hakoda M, et al. Detection of somatic mutations at the glycophorin A locus in erythrocytes of atomic bomb survivors using a single beam flow sorter. Cancer Res 1989;49:581-8.
21. Akiyama M, Kyoizumi S, Hirai Y, et al. Mutation frequency in human blood cells increases with age. Mutat Res 1995;338:141-9.
22. Peto R, Roe FJ, Lee PN, et al. Cancer and aging in mice and men. Br J Cancer 1975;32:411-26.
23. Balmain A, Gray J, Ponder B. The genetics and genomics of cancer. Nat Genet 2003;33 Suppl:238-44.
24. Thilly WG. Have environmental mutagens caused oncomutations in people? Nat Genet 2003;34:255-9.
25. Pierce DA, Mendelsohn ML. A model for radiation-related cancer suggested by atomic bomb survivor data. Radiat Res 1999;152:642-54.
26. Cloos J, Nieuwenhuis EJ, Boomsma DI, et al. Inherited susceptibility to bleomycin-induced chromatid breaks in cultured peripheral blood lymphocytes. J Natl Cancer Inst 1999;91:1125-30.
27. Roberts SA, Spreadborough AR, Bulman B, et al. Heritability of cellular radiosensitivity: a marker of low-penetrance predisposition genes in breast cancer? Am J Hum Genet 1999;65:784-94.
28. Wu X, Gu J, Hong WK. et al. Benzoapyrene diol epoxide and bleomycin sensitivity and susceptibility to cancer of upper aerodigestive tract. J Natl Cancer Inst 1998;90:1393-9.
29. Wu X, Gu J, Patt Y, et al. Mutagen sensitivity as a susceptibility marker for human hepatocellular carcinoma. Cancer Epidemiol Biomarkers Prev 1998;7:567-70.
30. Goss KH, Risinger MA, Kordich JJ, et al. Enhanced tumor formation in mice heterozygous for Blm mutation. Science 2002;297:2051-3.
31. Spring K, Ahangari F, Scott SP, et al. Mice heterozygous for mutation in Atm, the gene involved in ataxia-telangiectasia, have heightened susceptibility to cancer. Nat Genet 2002;32:185-90.
32. Shoemaker AR, Moser AR, Midgley CA, et al. A resistant genetic background leading to incomplete penetrance of intestinal neoplasia and reduced loss of heterozygosity in ApcMin/+ mice. Proc Natl Acad Sci U S A 1998;95:10826-31.
33. Tripodis N, Hart AA, Fijneman RJ, et al. Complexity of lung cancer modifiers: mapping of thirty genes and twenty-five interactions in half of the mouse genome. J Natl Cancer Inst 2001;93:1484-91.
34. de Boer JG. Polymorphisms in DNA repair and environmental interactions. Mutat Res 2002;509:201-10.
35. Hagmar L, Bonassi S, Stromberg U, et al. Chromosomal aberrations in lymphocytes predict human cancer: a report from the European Study Group on Cytogenetic Biomarkers and Health (ESCH). Cancer Res 1998;58:4117-21.
36. Hagmar L, Stromberg U, Bonassi S, et al. Impact of types of lymphocyte chromosomal aberrations on human cancer risk: results from Nordic and Italian cohorts. Cancer Res 2004;64:2258-63.
37. Neel JV, Satoh C, Smouse P, et al. Protein variants in Hiroshima and Nagasaki: tales of two cities. Am J Hum Genet 1988;43:870-93.
38. Shimizu Y, Kato H, Schull WJ. Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985: Part 2. Cancer mortality based on the recently revised doses (DS86). Radiat Res 1990;121:120-41.
39. Preston DL, Kusumi S, Tomonaga M, et al. Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987. Radiat Res 1994;137:568-97.
40. Kodama Y, Pawel D, Nakamura N, et al. Stable chromosome aberrations in atomic bomb survivors: results from 25 years of investigation. Radiat Res 2001;156:337-46.
41. Haber JE. Partners and pathways repairing a double-strand break. Trends Genet 2000;16:259-64.
42. Pierce AJ, Stark JM, Araujo FD, et al. Double-strand breaks and tumorigenesis. Trends Cell Biol 2001;11:S52-9.
43. Healey CS, Dunning AM, Teare MD, et al. A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability. Nat Genet 2000;26:362-4.
44. Winsey SL, Haldar NA, Marsh HP, et al. A variant within the DNA repair gene XRCC3 is associated with the development of melanoma skin cancer. Cancer Res 2000;60:5612-6.
45. 241Met) polymorphism and lung cancer risk. Cancer Epidemiol Biomarkers Prev 2001;10:911-2.
46. Butkiewicz D, Rusin M, Enewold L, et al. Genetic polymorphisms in DNA repair genes and risk of lung cancer. Carcinogenesis 2001;22:593-7.
47. Matullo G, Guarrera S, Carturan S, et al. DNA repair gene polymorphisms, bulky DNA adducts in white blood cells and bladder cancer in a case-control study. Int J Cancer 2001;92:562-7.
48. Fu YP, Yu JC, Cheng TC, et al. Breast cancer risk associated with genotypic polymorphism of the nonhomologous end-joining genes: a multigenic study on cancer susceptibility. Cancer Res 2003;63:2440-6.